Display options
Cite
Hicks RJ, Dromain C, de Herder WW, et al. ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. J Neuroendocrinol. 2021;e13040doi: 10.1111/jne.13040.
Hicks, R. J., Dromain, C., de Herder, W. W., Costa, F. P., Deroose, C. M., Frilling, A., Koumarianou, A., Krenning, E. P., Raymond, E., Bodei, L., Sorbye, H., Welin, S., Wiedenmann, B., Wild, D., Howe, J. R., Yao, J., O'Toole, D., Sundin, A., & Prasad, V. (2021). ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. Journal of neuroendocrinology, e13040. https://doi.org/10.1111/jne.13040
Hicks, Rodney J, et al. "ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours." Journal of neuroendocrinology vol. (2021): e13040. doi: https://doi.org/10.1111/jne.13040
Hicks RJ, Dromain C, de Herder WW, Costa FP, Deroose CM, Frilling A, Koumarianou A, Krenning EP, Raymond E, Bodei L, Sorbye H, Welin S, Wiedenmann B, Wild D, Howe JR, Yao J, O'Toole D, Sundin A, Prasad V. ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. J Neuroendocrinol. 2021 Sep 07;e13040. doi: 10.1111/jne.13040. Epub 2021 Sep 07. PMID: 34668262.
Copy Download .nbib Format: NLM
Share it on

J Neuroendocrinol. 2021 Sep 07;e13040. doi: 10.1111/jne.13040. Epub 2021 Sep 07.

ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours.

Journal of neuroendocrinology

Rodney J Hicks, Clarisse Dromain, Wouter W de Herder, Frederico P Costa, Christophe M Deroose, Andrea Frilling, Anna Koumarianou, Eric P Krenning, Eric Raymond, Lisa Bodei, Halfdan Sorbye, Staffan Welin, Bertram Wiedenmann, Damian Wild, James R Howe, James Yao, Dermot O'Toole, Anders Sundin, Vikas Prasad

Affiliations

  1. Neuroendocrine Service, The Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  2. Department of Radiology and University of Lausanne, Lausanne University Hospital, Lausanne, Switzerland.
  3. Department of Internal Medicine, Section of Endocrinology, Erasmus MC, Rotterdam, The Netherlands.
  4. Centro de Oncologia, Hospital Sírio Libanês, Sao Paulo, Brazil.
  5. Nuclear Medicine & Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium.
  6. Department of Surgery and Cancer, Hammersmith Hospital, Imperial College London, London, UK.
  7. Hematology Oncology Unit, 4th Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  8. Erasmus MC, Cyclotron Rotterdam BV, Rotterdam, The Netherlands.
  9. Medical Oncology, Hôspital Paris Saint-Joseph, Paris, France.
  10. Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  11. Department of Oncology and Department of Clinical Science, Haukeland University Hospital, Bergen, Norway.
  12. Endocrine Oncology, Uppsala University Hospital, Uppsala, Sweden.
  13. Charité Universitätsmedizin Berlin, Berlin, Germany.
  14. Department of Nuclear Medicine, University Hospital Basel, Basel, Switzerland.
  15. Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
  16. Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  17. Department of Clinical Medicine, St James's and St Vincent's University Hospitals & Trinity College Dublin, Dublin, Ireland.
  18. Department of Surgical Sciences, Radiology and Molecular Imaging, Uppsala University Hospital, Uppsala University, Uppsala, Sweden.
  19. Department of Nuclear Medicine, University Ulm, Ulm, Germany.

PMID: 34668262 DOI: 10.1111/jne.13040

Abstract

The European Neuroendocrine Tumor Society (ENETS) promotes practices and procedures that aim to improve the standard of care delivered to patients diagnosed with or suspected of having neuroendocrine neoplasia (NEN). At its annual Scientific Advisory Board Meeting in 2018, experts in imaging, pathology and clinical care of patients with NEN drafted guidance for the standardised reporting of diagnostic studies critical to the diagnosis, grading, staging and treatment of NEN. These included pathology, radiology, endoscopy and molecular imaging procedures. In an iterative process, a synoptic reporting template for molecular imaging procedures was developed to guide personalised therapies. Following pilot implementation and refinement within the ENETS Center of Excellence network, harmonisation with specialist imaging societies including the Society of Nuclear Medicine, European Association of Nuclear Medicine and the International Cancer Imaging Society will be pursued.

© 2021 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology.

Keywords: PET; neuroendocrine neoplasia; synoptic reporting

References

  1. Aide N, Lasnon C, Veit-Haibach P, Sera T, Sattler B, Boellaard R. EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies. Eur J Nucl Med Mol Imaging. 2017;44(Suppl 1):17-31. - PubMed
  2. Renshaw AA, Mena-Allauca M, Gould EW, Sirintrapun SJ. Synoptic reporting: evidence-based review and future directions. JCO Clin Cancer Inform. 2018;2:1-9. - PubMed
  3. Sluijter CE, van Lonkhuijzen LRCW, van Slooten H-J, Nagtegaal ID, Overbeek LIH. The effects of implementing synoptic pathology reporting in cancer diagnosis: a systematic review. Virchows Arch. 2016;468(6):639-649. - PubMed
  4. Bozkurt MF, Virgolini I, Balogova S, et al. Guideline for PET/CT imaging of neuroendocrine neoplasms with. Eur J Nucl Med Mol Imaging. 2017;44(9):1588-1601. - PubMed
  5. Hicks RJ. How I read cancer imaging studies: the master class series. Cancer Imaging. 2016;16:8. - PubMed
  6. Hofman MS, Hicks RJ. How we read oncologic FDG PET/CT. Cancer Imaging. 2016;16(1):35. - PubMed
  7. Sundin A, Arnold R, Baudin E, et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine & hybrid imaging. Neuroendocrinology. 2017;105(3):212-244. - PubMed
  8. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(Suppl 1):122S-150S. - PubMed
  9. Baker JA, Kornguth PJ, Floyd CE. Breast imaging reporting and data system standardized mammography lexicon: observer variability in lesion description. AJR Am J Roentgenol. 1996;166(4):773-778. - PubMed
  10. Elsayes KM, Kielar AZ, Chernyak V, et al. LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance. J Hepatocell Carcinoma. 2019;6:49-69. - PubMed
  11. Steiger P, Thoeny HC. Prostate MRI based on PI-RADS version 2: how we review and report. Cancer Imaging. 2016;16:9. - PubMed
  12. Werner RA, Bundschuh RA, Bundschuh L, et al. Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implications. Ann Nucl Med. 2018;32(8):512-522. - PubMed
  13. Chan D, Pavlakis N, Schembri G, et al. Dual somatostatin receptor/FDG PET/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance. Theranostics. 2017;7(5):1149-1158. - PubMed
  14. Hicks RJ. Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy. Cancer Imaging. 2010;10:83 Spec no A:S83-91. - PubMed
  15. Garin E, Le Jeune F, Devillers A, et al. Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors. J Nucl Med. 2009;50(6):858-864. - PubMed
  16. Barrington SF, Mikhaeel NG, Kostakoglu L, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32(27):3048-3058. - PubMed

Publication Types

Grant support